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Caloric restriction (CR) has been shown to possess antiepileptic properties; however
its mechanism of action is poorly understood. CR might inhibit the activity of the
mammalian or mechanistic target of rapamycin (mTOR) signaling cascade, which seems
to participate crucially in the generation of epilepsy. Thus, we investigated the effect
of CR on the mTOR pathway and whether CR modified epilepsy generation due to
electrical amygdala kindling. The former was studied by analyzing the phosphorylation of
adenosine monophosphate-activated protein kinase, protein kinase B and the ribosomal
protein S6. The mTOR cascade is regulated by energy and by insulin levels, both of
which may be changed by CR; thus we investigated if CR altered the levels of energy
substrates in the blood or the level of insulin in plasma. Finally, we studied if CR modified
the expression of genes that encode proteins participating in the mTOR pathway.
CR increased the after-discharge threshold and tended to reduce the after-discharge
duration, indicating an anti-convulsive action. CR diminished the phosphorylation of
protein kinase B and ribosomal protein S6, suggesting an inhibition of the mTOR
cascade. However, CR did not change glucose, β-hydroxybutyrate or insulin levels; thus
the effects of CR were independent from them. Interestingly, CR also did not modify the
expression of any investigated gene. The results suggest that the anti-epileptic effect of
CR may be partly due to inhibition of the mTOR pathway.
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Introduction
At first glance neurodegenerative diseases and epilepsy may seem to have little in
common. However, upon further research it is clear that they are surprisingly simi-
lar. As an example, abnormal neural activity -the hallmark of epileptic disorders- might
cause the synaptic and cognitive deficits observed in neurodegenerative diseases (Sanchez
et al., 2012). Another unexpected commonality between neurodegenerative diseases and
Abbreviations: CR, caloric restriction; mTOR, mechanistic target of rapamycin; β-HB, β-hydroxybutyrate; AMPK, adeno-
sine monophosphate-activated protein kinase; PKB/Akt, protein kinase B; S6, ribosomal protein S6; S6K, ribosomal protein
S6 kinase; TSC2, tuberous sclerosis 2; AL, ad libitum; AD, after-discharge; Cx, neocortex; Hp, hippocampus.
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epilepsy may be a defect of autophagy (Wong, 2013; Lipton and
Sahin, 2014) due to dysfunction of the mammalian or mechanis-
tic target of rapamycin (mTOR) signaling pathway (Wong, 2013;
Lipton and Sahin, 2014).
The ketogenic diet is a beneficial treatment for epilepsy that
is frequently used in the clinic (Kossoff and Wang, 2013; Wang
and Lin, 2013). Similarly, caloric restriction (CR) is a diet that
has anti-epileptic and anti-epileptogenic effects in different ani-
mal models (Greene et al., 2001; Bough et al., 2003). Their
mechanism of action is poorly understood; however it has been
reported that the ketogenic diet might inhibit the mTOR cascade
(McDaniel et al., 2011). Excessive activation of this pathway has
been observed in diverse models of genetic or acquired epilepsy,
suggesting that aberrant function of this cascade plays a crucial
role in epilepsy generation (Wong, 2013; Lipton and Sahin, 2014).
CR may also inhibit the mTOR pathway in yeast, flies and nema-
todes (Kapahi et al., 2004; Kaeberlein et al., 2005; Walker et al.,
2005).
The mTOR cascade regulates protein synthesis and cell
growth, among other things (Figure 4; Wong, 2013; Lipton and
Sahin, 2014). Insulin and growth factors result in protein kinase B
(PKB or Akt) phosphorylation, which inhibits tuberin (tuberous
sclerosis 2 or TSC2). In contrast, TSC2 is activated by adenosine
monophosphate-activated protein kinase (AMPK) in response to
energy deficits. TSC2, together with hamartin (tuberous sclero-
sis 1 or TSC1), inhibits the activity a complex which includes
the mTOR protein. This complex activates ribosomal protein S6
kinase (S6K), which phosphorylates ribosomal protein S6 (S6).
These proteins only function when phosphorylated at specific
residues. Therefore, the only way to study their activity with the
western blot technique is to probe with antibodies that only can
recognize the protein when phosphorylated at one or more of
these residues.
CR may not hinder the mTOR cascade in all mammalian tis-
sues (Sharma et al., 2012). We thus studied whether CR inhibits
the mTOR pathway in the hippocampus and the adjacent tem-
poral neocortex to clarify this issue. This was done by analyzing
the phosphorylation of the α1/2 subunits of AMPK, PKB and S6
using the western blot technique. In addition, we also investigated
if CRmodified the expression of genes encoding for proteins par-
ticipating in the mTOR cascade. This pathway is regulated by
energy and insulin levels, whichmight be changed by CR; thus we
also studied whether CR altered the blood levels of glucose or β-
hydroxybutyrate (β-HB) or the plasma concentration of insulin.
Finally, we investigated the anti-epileptogenic effects of CR using
electrical kindling of the amygdala, which allows investigation
of epilepsy generation. The hippocampus and the adjacent tem-
poral neocortex were chosen because the amygdala projects to
the hippocampus and the adjacent temporal neocortex presum-
ably includes hippocampal projection areas. In opposition, the
amygdala was not analyzed to minimize any possible influence of
electrode placement within it.
Most prior studies used weanling animals, since the ketogenic
diet might be more effective the younger the animal (Bough
et al., 1999). Thus, we used young rats due to the precedent set
by previous reports. Additionally, the susceptibility to epilepsy
is very high in childhood (Kotsopoulos et al., 2002). CR was
accomplished by food restriction without vitamin or mineral
supplementation; therefore the rats were subjected to mild CR
(15%) to avoid any concerns relating to under-nutrition, espe-
cially given their young age. This low degree of CR was also
selected given prior studies (Greene et al., 2001; Raffo et al., 2008;
Linard et al., 2010).
Materials and Methods
Animal Handling
20 male Wistar rats were purchased from Harlan Laboratories
at postnatal day 21 and then subjected to a 4 h fast to insure
that all animals started at a similar metabolic set point. After-
wards, the rats were weight-matched and assigned to four groups:
(1) 5 fed ad libitum (control), (2) 5 allowed to feed ad libitum
and subjected to the kindling procedure (kindled control), (3)
5 calorically restricted (experimental) and (4) 5 subjected to CR
plus kindling (kindled experimental). CR was achieved by feed-
ing rats with a normal diet (2018S, Harlan Laboratories) to 85%
of the daily allowance based on the body weights (recorded every
day) of rats allowed to feed ad libitum (Rogers, 1979). The ani-
mals were kept 30 days on their respective diets before stereotaxic
surgery; each group was housed separately under standard con-
ditions. Rat management was performed according to the princi-
ples of the guide for the care and use of laboratory animals and
NIH publication 85-23, 1985.
Stereotaxic Surgery
A group of rats fed ad libitum and a group of animals sub-
jected to CR were operated, while the other 2 groups served as
control groups. After deep ketamine (40mg/kg) anesthesia was
achieved, bipolar electrodes were implanted within the left baso-
lateral amygdala and right sensory cortex (stereotaxic coordi-
nates: anterior 2.8, 6.7mm; lateral 5, 2.5mm; ventral 8.5, 9mm;
from bregma and the interaural line, respectively). The electrodes
consisted of two twisted strands of stainless steel (0.005′diameter)
coated with Teflon, except the tips which were separated by 0.02′.
They were soldered to connectors and fastened to the skull with
acrylic cement and screws, a screw served as an indifferent source
of isoelectric reference. Electrode placement was verified by per-
forming histological staining techniques after the animals were
sacrificed.
Electrical Kindling of the Amygdala
The after-discharge (AD) threshold, defined as the lowest elec-
trical stimulus that elicited an amygdala AD lasting at least 5 s
(from the end of the stimulus), was determined after the rats were
allowed to recover from surgery for a period of at least 10 days.
We employed an electronic circuit breaker device that switched
to either the polygraph (Grass 78D, Grass Technologies) or the
stimulator (Grass S88, Grass Technologies) connected to the elec-
trode placed in the amygdala (1.8 cm long). This allowed us to
stimulate and record through this electrode (Ferrer et al., 1978).
The electrode located within the sensory cortex (1.5 cm long)
served to verify propagation of epileptic activity (supplementary
figure). The electrical signal was amplified 1000x and processed
with a 16-bit sigma delta converter at a sampling frequency of
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256Hz. The recordings were monitored and saved for off-line
analysis with Harmonie v.5.2 software (Stellate Systems).
After 2min of polygraphic recording to establish the basal
activity, the amygdala was stimulated for 1 s with rectangular
pulses of 1ms at 60Hz (Paz et al., 1991). The first stimula-
tion intensity was 5V followed by subsequent increments of 1V
until elicitation of an AD (the intensity eliciting an AD last-
ing at least 5 s from the end of the stimulus was defined as the
AD threshold). In the following daily trials, the threshold inten-
sity was applied until at least 5 consecutive generalized con-
vulsive (stage 5) seizures were obtained. Seizure severity was
scored according to behavioral criteria; briefly: stage 1-mouth
and facial movements, stage 2-head nodding, stage 3-forelimb
clonus, stage 4-rearing, stage 5-rearing and falling (Racine, 1972).
We measured the following kindling parameters: AD threshold
and duration, latency to each Racine stage (number of stim-
ulations/days required to reach each Racine stage), latency to
reach criterion (number of stimulations/days needed to reach 5
consecutive generalized stage 5 convulsive seizures), number of
stimulations/days where the rats showed each Racine stage and
number of stimulations/days the animals had either focal con-
vulsive seizures (stages 1–3) or generalized convulsive seizures
(stages 4–5). The intracranial electroencephalographic activity of
the amygdala and the sensory cortex was captured using a signal
capture software (Galileo, Stellate Systems) and merged with dig-
ital video records (Diva, Stellate Systems). All the animals were
sacrificed the day after kindled rats were last stimulated (for a
total of 64 days subjected to CR, postnatal day 85).
Blood and Plasma Measurements
Glucose and β-HB levels were measured with a digital mon-
itor system (MediSense Optium Xceed, Abbott Laboratories)
after a 4 h fast, before beginning the experiment and once it
ended, using blood samples collected from the tail vein. Blood
was also obtained after a 4 h fast at sacrifice and processed to
obtain plasma, which was kept at −70◦C. The plasma was used
to determine the insulin concentration by an enzyme-linked
immunosorbent assay (Alpco Diagnostics) according to standard
protocols.
Hippocampus and Temporal Neocortex Samples
The brain was obtained rapidly and the hippocampus (Hp) plus
adjacent temporal neocortex (Cx) were micro-dissected quickly,
separated and cut into two portions. The samples were frozen
with liquid nitrogen and stored at−70◦C. One piece was homog-
enized at 4◦C with a lysis buffer (pH 7) containing (in mM):
50 Tris, 150 NaCl, 1 EGTA, plus phosphatase and protease
inhibitors. After a 30min incubation at 4◦C, the homogenate was
centrifuged at 16,000 g for 10min at 4◦C and the supernatant was
recovered. The concentration of total protein was determined
using the Lowry method.
The other fragment of each brain area was homogenized
at 4◦C with Trizol to obtain total RNA. Briefly, the proto-
col included chloroform addition, centrifugation at 12,000 g
for 15min at 4◦C, isopropanol addition, centrifugation at
12,000 g for 10min at 4◦C and addition of ethanol followed
by centrifugation at 7500 g for 10min at 4◦C. The rest of the
brain was fixed with 4% paraformaldehyde, cryo-preserved in a
30% sucrose solution, frozen, cut and processed by histological
staining techniques to verify electrode placement.
Western Blotting
Fifty Microgram/Microliter of protein was separated in a
10% SDS-PAGE gel under denaturing conditions, transferred
to PVDF membranes and probed with: phospho-AMPKα
(Thr172), AMPKα, phospho-PKB (Thr308), PKB/Akt, phospho-
S6 (Ser235/236) or S6 (all from Cell Signaling Technology).
The membranes were revealed utilizing a chemiluminescence
assay and the amount of protein was analyzed utilizing Quan-
tity One software (Bio-Rad Laboratories). Actin, detected with
an antibody (Sigma-Aldrich Corporation), was used as loading
control.
Quantitative Real-Time Polymerase Chain
Reaction
Complementary DNA was obtained from total RNA by retro-
transcription utilizing the M-MLV reverse transcriptase enzyme
and random hexamers (Applied Biosystems) using the 2400
Geneamp PCR system (Perkin Elmer Inc.). The analysis of rel-
ative gene expression levels was done by quantitative real-time
polymerase chain reaction using TaqMan gene expression assays.
The procedure was performed following the instructions pro-
vided by the supplier (Applied Biosystems). The analyzed genes
were: the α1 and α2 catalytic subunits of AMPK, mTOR, tuber-
ous sclerosis 1 (TSC1), TSC2 and ribosomal protein S6 kinase
(S6K, polypeptide 1). The level of these genes was normalized
against the expression of the gene that encodes the eukaryotic 18S
FIGURE 1 | Body weight gain in male rats fed ad libitum (AL) or
subjected to 15% caloric restriction (CR) from postnatal day 21
(experimental day 1) to postnatal day 75 (day 54 of the procedure). The
points were fit with logistic growth curves. The asterisk indicates the start of
statistically significant differences (p < 0.05) among the groups (all other
successive comparisons met this criterion).
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rRNA (endogenous control) using the difference in cycle thresh-
old method with the StepOne real-time PCR system (Applied
Biosystems).
Statistics
Unpaired student’s t-tests were performed to evaluate differences
between kindled animals and those not subjected to kindling
FIGURE 2 | Systemic concentration of energy substrates and the
hormone insulin at the initial and final time points of the experiment
in animals allowed food ad libitum (AL) or exposed to 15% caloric
restriction (CR). (A) Blood β-hydroxybutyrate (β-HB) levels (mmol/l). (B)
Blood glucose concentrations (mg/dl). (C) Plasma insulin levels (ng/ml).
##p ≤ 0.01 and ### p ≤ 0.001, initial vs. final.
FIGURE 3 | Effect of caloric restriction (CR) upon electrical
kindling of the amygdala. (A) After-discharge threshold (%)
determined the first day of the kindling procedure in rats fed ad
libitum (AL) or subjected to 15% CR for at least 40 days. (B)
After-discharge duration (in seconds) during kindling. ∗p ≤ 0.05,
∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, AL vs. CR.
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(control vs. kindled control, experimental vs. kindled experimen-
tal). All the variables behaved similarly between these groups
(Supplementary Data). Thus, control and kindled control data
were pooled together (hereafter AL, n = 10) and the results
for experimental and kindled experimental rats were combined
(henceforth CR, n = 10) for all subsequent analysis. Dissimi-
larities in body weight were evaluated utilizing two-way analysis
of variance tests for each pair of days followed by Holm-Sidak
post-hoc tests. The differences between groups (AL vs. CR) were
evaluated using unpaired student’s t-tests, whereas dissimilari-
ties among groups (before vs. after) were analyzed with paired
student’s t-tests. A p ≤ 0.05 was considered to be significantly
different. Figure data were expressed as mean± standard error.
Results
Bio-Indexes
Body weights increased in both groups (Figure 1), but mild CR
significantly reduced the weight gain of young animals [i.e., AL
vs. CR in days 6 vs. 7: F(1, 16) = 6.20, p < 0.05, t = 2.49;
for all other comparisons see Supplementary Data]. On the
other hand, fasting blood glucose and β-HB as well as plasma
insulin (Figure 2) were similar between the groups [initial glu-
cose: t(1, 18) = −0.14, p = 0.89; final glucose: t(1, 18) = 0.09,
p = 0.93; initial β-HB: t(1, 18) = −0.15, p = 0.88; final β-HB:
t(1, 18) = 0.50, p = 0.62; plasma insulin: t(1, 18) = 0.371, p =
0.72]. Nonetheless, β-HB decreased whereas glucose increased
significantly with time in both groups [initial vs. final; AL glu-
cose: t(1, 9) = −9.00, p ≤ 0.001; CR glucose: t(1, 9) = −13.33,
p ≤ 0.001; AL β-HB: t(1, 9) = 4.03, p < 0.01 and CR β-HB:
t(1, 9) = 4.96, p ≤ 0.001].
Electrical Kindling of the Amygdala
CR significantly increased [t(1, 8) = −3.35, p = 0.01] the AD
threshold (Figure 3A) and reduced the AD duration in days 14
[t(1, 8) = 2.73, p < 0.05], 15 [t(1, 8) = 4.63, p < 0.01]
and 16 [t(1, 8) = 2.92, p < 0.05] of the kindling procedure
(Figure 3B). However, CR did not significantly alter the AD
duration in any other day nor did it affect any other kindling
parameter (latency to each Racine stage: AL 4.0 ± 1.0 vs. CR
3.8 ± 0.2 to stage 2, AL 8.7 ± 2.3 vs. CR 9.2 ± 1.1 to stage
3, AL 11.7 ± 1.2 vs. CR 12.8 ± 1.7 to stage 4, AL 13.7 ± 0.9
vs. CR 14.6 ± 2.0 to sage 5; latency to criterion: 17.7 ± 0.9 vs.
18.6 ± 2.0; days in each Racine stage: AL 3.0 ± 1.0 vs. CR 2.8
± 0.2 in stage 1, AL 4.7 ± 1.5 vs. CR 5.4 ± 1.0 in stage 2, AL
3.0 ± 1.2 vs. CR 3.6 ± 1.4 in stage 3, AL 2.0 ± 1.0 vs. CR
1.8 ± 0.4 in stage 4, AL 9.3 ± 0.7 vs. CR 9.4 ± 0.7 in stage 5;
days with focal convulsive seizures: AL 10.7 ± 1.2 vs. CR 11.8
± 1.7; days rats had generalized convulsive seizures: AL 11.3 ±
0.3 vs. CR 11.2 ± 0.5; statistical comparisons in Supplementary
Data).
mTOR Signaling Pathway
CR tended to augment AMPK phosphorylation (Figures 4, 5) in
the Cx [t(1, 18) = −1.47, p = 0.16] and significantly increased
AMPK phosphorylation in the Hp [t(1, 18) = −2.44, p < 0.05].
CR significantly reduced PKB/Akt and S6 phosphorylation in the
Cx [PKB: t(1, 18) = 3.03, p < 0.01 and S6: t(1, 18) = 2.13,
p < 0.05] and Hp [PKB: t(1, 18) = 3.13, p < 0.01 and S6:
t(1, 18) = 2.39, p < 0.05], suggesting that CR inhibited the mTOR
cascade. Finally, CR did not significantly change the expression
level of the studied genes [Figure 6; AMPKα1: Cx: t(1, 18) = 0.40,
p = 0.70, Hp: t(1, 18) = 0.62, p = 0.54; AMPKα2: Cx: t(1, 18) =
1.37, p = 0.19, Hp: t(1, 18) = 0.57, p = 0.58; mTOR: Cx:
t(1, 18) = −1.09, p = 0.29, Hp: t(1, 18) = −1.71, p = 0.10; S6K:
Cx: t(1, 18) = 1.78, p = 0.09, Hp: t(1, 18) = 0.08, p = 0.94; TSC1:
Cx: t(1, 18) = 1.74, p = 0.10, Hp: t(1, 18) = −1.33, p = 0.20;
TSC2: Cx: t(1, 18) = 0.27, p = 0.79, Hp: t(1, 18) = 0.58, p = 0.57].
Discussion
Body Weight
Interestingly, mild CR significantly diminished weight gain of
weanling rats; therefore our concerns with under-nutrition were
well founded. This is not a universal finding given that some stud-
ies have shown a similar decrease in body weight (Greene et al.,
2001; Cheng et al., 2003, 2004; Eagles et al., 2003), whereas other
reports have not (Bough et al., 1999, 2003; Raffo et al., 2008).
These contradictory findings have been mostly ignored, perhaps
because little explanation can be offered as to the reasons for
these discrepancies. The age at diet onset and length of time on it
are the most likely factors that may account for the inconsistent
results regarding the effect of CR on body weight. It is impor-
tant to note that a reduction in body weight gain is consistent
with an inhibition of the mTOR pathway. Even if a decrease in
FIGURE 4 | (A) Brief diagram of the mechanistic target of rapamycin (mTOR)
pathway with analyzed proteins/genes (black arrows, activation; red lines,
inhibition; AMPK, adenosine monophosphate-activated protein kinase; PKB,
protein kinase B; TSC1, tuberous sclerosis 1; TSC2, tuberous sclerosis 2;
S6K, ribosomal protein S6 kinase; S6, ribosomal protein S6). (B)
Representative blots showing both phosphorylated (p) and total AMPK, PKB
and S6 in the neocortex (Cx) and hippocampus (Hp) of rats fed ad libitum (AL)
or subjected to 15% caloric restriction (CR). The molecular weight (MW) is
shown in kilodaltons (kDa) to the right of each protein pair.
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FIGURE 5 | Phosphorylation of proteins participating in the
mechanistic target of rapamycin signaling pathway in the neocortex
(Cx) and hippocampus (Hp) of animals allowed to feed ad libitum (AL)
or subjected to a 15% caloric restriction (CR). (A) Expression of
phospho-AMPK against total AMPK. (B) Proportion of phospho-PKB vs. total
PKB. (C) Phospho-S6 to total S6 ratio. ∗p ≤ 0.05, ∗∗p ≤ 0.01, AL vs. CR.
body weight was observed, CR showed anti-epileptic actions in all
reports. Thus, it is unlikely the animals were malnourished given
the adverse effects of malnutrition on epilepsy (Crepin et al.,
2009).
Biochemical Parameters
Blood glucose or β-HB and plasma insulin were similar between
the groups, again showing that CR did not result in under-
nutrition. The normal developmental profile of increasing glu-
cose and decreasing β-HB levels was observed (Edmond et al.,
1985; Prins, 2012). CR has not been reported to affect blood β-HB
levels in rats (Bough et al., 1999; Cheng et al., 2003, 2004; Eagles
et al., 2003; Raffo et al., 2008; Linard et al., 2010), except for one
report (Bough et al., 2003). On the other hand, Sprague-Dawley
rats exposed to CR starting at weaning for 7 days had lower blood
glucose compared to animals fed ad libitum (Cheng et al., 2003,
2004). In contrast, no significant alterations were seen in blood
glucose levels of Wistar rats subjected to CR for 3 weeks starting
at postnatal day 50 (Raffo et al., 2008; Linard et al., 2010). The
most probable explanation is that the animals in the latter stud-
ies and ours adapted their metabolism to CR due to its duration,
though other factors (species, age at diet onset) might account for
the discordant findings. For example, CR significantly increased
blood β-HB and decreased glucose levels in mice; suggesting a
species difference (Greene et al., 2001; Mahoney et al., 2006). The
finding that CR did not modify glucose, β-HB or insulin levels is
very important because any effects of CR are thus independent
from them.
Electrical Kindling of the Amygdala
CR significantly increased the after-discharge threshold and
diminished the after-discharge duration in a few days of the
kindling procedure, but did not meaningfully alter any other
kindling parameter. The number of stimulations to a generalized
convulsive seizure (stage 5), known as the kindling rate, is a mea-
sure of the epileptogenic capability in this model. 15% CR did
not alter the kindling rate in Wistar rats, thus CR was not anti-
epileptogenic in these outbred animals. The anti-epileptogenic
action of CR has been validated in mice and rats inbred for
epileptic susceptibility (Greene et al., 2001; Azarbar et al., 2010),
generating doubts whether CR really can be anti-epileptogenic
in humans. However, a higher degree of CR likely has anti-
epileptogenic effects in outbred animal models and humans. This
is to be expected if a higher degree of CR has more prominent
inhibitory effects on the mTOR signaling cascade. Alternatively,
the anti-epileptogenic action of CR may require reductions in
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FIGURE 6 | Gene expression in the neocortex and hippocampus of
rats fed ad libitum (AL) or exposed to 15% caloric restriction (CR). (A)
Comparison of tuberous sclerosis 2 (TSC2), (B) Semi-quantitative levels of
the α2 catalytic subunit of the adenosine monophosphate-activated protein
kinase (AMPK) and the mechanistic target of rapamycin (mTOR) genes, (C)
Relative level of the α1 catalytic subunit of AMPK, ribosomal protein S6
kinase (S6K) and TSC1 genes. There were no significant differences between
the groups.
glucose or insulin and/or an increase in β-HB (Greene et al., 2001;
Yamada, 2008).
Increases in the after-discharge threshold can be predictive
of the anti-convulsive capacity of drugs in pharmacological tests
(Azarbar et al., 2010). Similarly, since the after-discharge is an
electrographic seizure, a reduction in its duration is an anti-
convulsive effect (Azarbar et al., 2010). CR augmented the after-
discharge threshold and reduced its duration, without affecting
any other kindling variable (most importantly the kindling rate).
This suggests an anti-convulsive profile rather than an anti-
epileptogenic action; which is totally independent from changes
in glucose, insulin or β-HB.
mTOR Signaling Cascade
Mild CR significantly augmented AMPK phosphorylation in the
hippocampus. Besides, it reduced PKB/Akt and S6 phosphoryla-
tion in the temporal neocortex and the hippocampus; suggesting
that even mild CR inhibits the mTOR signaling pathway. Simi-
larly, mice which were subjected to 30% CR starting at 3 months
of age for 9 or 17 months showed reduced PKB/Akt and S6K
phosphorylation levels in the hippocampus, suggesting that CR
hindered this cascade (Yang et al., 2014). In contrast, 35–40%
CR starting at 3–4 months of age for 6 months in Fischer 344
and Brown Norway F1 rats did not affect the phosphorylation
level of several proteins that participate in this pathway in the
cerebellum or neocortex (Sharma et al., 2012). These discordant
findings are probably explained by the age at diet onset or its
duration, although factors such as species, strain and brain region
may have influenced the results.
The results suggest that CR inhibited the mTOR cascade in the
hippocampus and adjacent temporal neocortex after the animals
showed 5 consecutive generalized convulsive seizures (postnatal
day 75). Thus, the status of the mTOR pathway in the amygdala
when the after-discharge threshold (postnatal day 55) and dura-
tion (postnatal days 55–75) were determined is unknown. How-
ever, rats subjected to CR had been on this diet for at least 40 days
before the kindling procedure started, thus CR probably likewise
hindered the mTOR cascade in the amygdala. Furthermore, the
effects of CR on the after-discharge threshold and duration were
consistent with its known effects (Bough et al., 1999, 2003; Eagles
et al., 2003; Azarbar et al., 2010) and consistent with regulation of
neuron/network excitability by the mTOR cascade (Lasarge and
Danzer, 2014; Lipton and Sahin, 2014).
Mild CR (15%) for 55 days starting on postnatal day 21 (this
study) did not significantly change AMPKα1, AMPKα2, mTOR,
S6K, TSC1, or TSC2 expression in the hippocampus or tem-
poral neocortex. In agreement, 20% CR for 6 months starting
at 4 months of age did not significantly affect gene expression
of proteins involved in the mTOR cascade in the hippocam-
pus of Sprague-Dawley rats. However, 40% CR augmented the
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expression of genes involved in this pathway (Martin et al., 2008).
These results show that the degree of CR is a very important fac-
tor determining the results. Similarly, 30–40% CR starting at 3–4
months of age for ≥6 months (Sharma et al., 2012; Yang et al.,
2014) did not alter the level of mTOR, S6K or TSC2 expression in
the hippocampus, neocortex or cerebellum. But 30% CR for vari-
able times (∼4, 11, 18, or 23 months) starting at weaning reduced
the expression of genes that participate in this cascade (such as
S6K) in the hypothalamus of inbredmice (Wu et al., 2009). Given
the similarity between two of these reports (Wu et al., 2009; Yang
et al., 2014), the most likely explanation is that CR has differen-
tial impact depending on the age at diet onset or the brain region,
as previously suggested (Zeier et al., 2011). Although CR and the
ketogenic diet both inhibit the mTOR pathway (McDaniel et al.,
2011), this is unlikely to be the only anti-epileptic mechanism of
action of these treatments since they differ in important respects
(Bough et al., 2000, 2003; Hartman et al., 2010). This is empha-
sized by the fact that the ketogenic diet has anti-epileptogenic
effects (Jiang et al., 2012), whereas mild CR displayed a profile
more consistent with an anti-convulsive action.
Our findings suggest using CR as a therapeutic intervention to
inhibit the mTOR cascade in the human brain. The advantage of
CR is that it can be combined with other treatments; this is gener-
ally done when using the ketogenic diet (Kossoff andWang, 2013;
Wang and Lin, 2013). Moreover, CR may be used for seizure-
epilepsy prophylaxis; althoughmore studies are needed to resolve
current contradictory findings (Zeng et al., 2010; Macias et al.,
2013). Unfortunately, even mild CR significantly reduced weight
gain in weanling rats which may limit its use in children and
adolescents due to concerns regarding their growth. In addition,
despite the presumed inhibition of the mTOR pathway all the rats
progressed to generalized convulsive seizures with the same kin-
dling rate. This was probably due to the low degree of CR used;
a higher amount of CR likely would result in anti-epileptogenic
effects.
In summary, CR elevated the after-discharge threshold with-
out changes in other kindling variables; suggesting an anti-
convulsive action. CR increased AMPK phosphorylation in the
hippocampus, while it decreased phosphorylation of PKB/Akt
and S6 in the temporal neocortex and hippocampus; implying an
inhibition of the mTOR signaling cascade. The effects of CR were
likely independent from any changes in glucose, β-HB, insulin
or gene expression (AMPKα1, AMPKα2, mTOR, S6K, TSC1, or
TSC2) since none were modified by CR. Our main conclusion is
that CR may inhibit the mTOR signaling cascade in the brain,
which results in an anti-convulsive increase in convulsive seizure
threshold that does not depend on changes in energy or insulin
levels or gene expression of proteins that participate in this cas-
cade. Thus, CR might be used as a therapeutic tool to inhibit the
mTOR pathway to achieve anti-convulsive effects.
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